What is the appropriate next step in managing persistent mouth sores on the posterior tongue after a normal esophagogastroduodenoscopy (EGD) and partial response to Nystatin?

Escalate to Oral Fluconazole for Nystatin-Refractory Oral Candidiasis

For persistent mouth sores on the posterior tongue that partially responded to nystatin, you should switch to oral fluconazole 100-200 mg daily for 7-14 days, as this represents moderate disease that is inadequately controlled by topical therapy 1.

Clinical Reasoning

Your patient's partial response to nystatin confirms the diagnosis is likely oral candidiasis, but the incomplete resolution indicates either:

• Inadequate nystatin formulation or duration
• Moderate-to-severe disease requiring systemic therapy
• Potentially resistant Candida species

The normal EGD rules out esophageal extension, so you're dealing with isolated oropharyngeal disease.

Treatment Algorithm

First-Line Escalation (Current Situation)

• Oral fluconazole 100-200 mg daily for 7-14 days 1
  • This is the guideline-recommended treatment for moderate disease
  • Strong recommendation with high-quality evidence
  • Superior efficacy compared to topical agents for persistent cases

Why Nystatin Failed

The partial response suggests several possibilities:

Formulation matters significantly:

• Nystatin pastilles maintain antifungal activity for 5+ hours in the oral cavity 2
• Nystatin suspension loses activity rapidly (within minutes) 2
• If your patient used suspension alone, this explains the inadequate response
• Combination therapy (pastilles + suspension) achieves higher cure rates than suspension alone 3

Dosing and duration:

• Standard nystatin suspension: 4-6 mL (400,000-600,000 units) 4 times daily 1
• Pastilles: 200,000 units, 1-2 pastilles 4 times daily 1
• Treatment duration should be 7-14 days minimum 1

If Fluconazole Fails

Should fluconazole prove ineffective (fluconazole-refractory disease), escalate to:

1. Itraconazole solution 200 mg once daily for up to 28 days 1

   • OR Posaconazole suspension 400 mg twice daily × 3 days, then 400 mg daily 1
   • Strong recommendation with moderate-quality evidence

2. Alternative second-line options:

   • Voriconazole 200 mg twice daily 1
   • Amphotericin B deoxycholate oral suspension 100 mg/mL 4 times daily (requires compounding) 1

3. Intravenous therapy for severe refractory cases:

   • Echinocandins (caspofungin, micafungin, anidulafungin) 1
   • Reserved for truly refractory disease

Critical Considerations

Assess for underlying immunosuppression:

• HIV/AIDS (CD4 count if not known)
• Diabetes mellitus
• Corticosteroid use
• Recent broad-spectrum antibiotics
• Malignancy or chemotherapy

Denture-related candidiasis:

• If patient wears dentures, disinfection of the denture is mandatory in addition to antifungal therapy 1
• This is a strong recommendation with moderate-quality evidence

Chronic suppressive therapy:

• Generally unnecessary unless recurrent infections occur 1
• If needed: fluconazole 100 mg three times weekly 1

Common Pitfalls to Avoid

1. Don't continue nystatin indefinitely - partial response indicates need for escalation, not prolonged inadequate therapy
2. Don't assume all nystatin formulations are equal - pastilles are significantly more effective than suspension due to prolonged oral contact time 2
3. Don't overlook dentures - failure to disinfect dentures leads to treatment failure and reinfection 1
4. Don't miss immunosuppression - persistent/recurrent candidiasis warrants evaluation for underlying immune dysfunction 1

Safety Profile

Fluconazole is generally well-tolerated. Nystatin's most common adverse effects are poor taste and gastrointestinal upset 4, 3, which may have contributed to suboptimal adherence if your patient experienced these.